Controlled Release Excipient

Abstract Purpose Cabazitaxel (CBZ) is a semi-synthetic anti-cancer drug and belongs to BCS class IV category with poor water solubility...

Abstract Background/Objectives: Rebamipide is a gastroprotective agent with poor aqueous solubility and rapid gastrointestinal clearance, leading to reduced therapeutic efficiency. This...

Abstract The rapid development of artificial intelligence (AI) and the increasing demand for the modernization of Chinese herbal medicine (CHM)...

Abstract Aqueous colloidal dispersions of water-insoluble polymers (APDs) —commonly referred to as pharmaceutical latexes or pseudolatexes— are extensively employed in...

CELLETS® Pharmaceutical Starter Cores for Pellets & Functional Coatings CELLETS® are high-purity pharmaceutical starter cores. They combine spherical geometry with...

Abstract SmartLipids represent the third generation of lipid-based nanocarriers, emerging as a transformative innovation in modern drug delivery and formulation...

Abstract Background: Pantoprazole is a widely used proton pump inhibitor that is highly unstable under acidic conditions. This limits the performance...

Abstract The aim of this study was to develop a once-daily controlled-release (CR) apixaban (APX) formulation that enhances bioavailability through...

Abstract The presented work investigates critical aspects of rational formulation design through machine learning (ML) methodology to identify essential patterns...

Abstract Aims The objective of the present study was to develop and characterize tamoxifen (TAM)-loaded TPGS-PLGA nanoparticles (NPs) for more...